Diclofenac Potassium Powder, For Solution
NDC Package 75834-338-01
Package Information
Diclofenac Potassium powders is diclofenac is used to relieve pain and swelling (inflammation) from various mild to moderate painful conditions. This formulation utilizes a powder, for solution delivery system. Marketed by Nivagen Pharmaceuticals, Inc., this product is identified by NDC 75834-338 and is authorized under FDA application ANDA217010.
Identification & Billing
- RxCUI: 859063 - diclofenac potassium 50 MG Powder for Oral Solution
- RxCUI: 859063 - Diclofenac K+ 50 MG Powder for Oral Solution
- RxCUI: 859063 - Diclofenac Pot 50 MG Powder for Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 75834 - Nivagen Pharmaceuticals, Inc.
- 75834-338 - Diclofenac Potassium
- 75834-338-01 - 1 POWDER, FOR SOLUTION in 1 PACKET
- 75834-338 - Diclofenac Potassium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (75834-338). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 75834-338-01 identifies a specific commercial package of 1 powder, for solution in 1 packet of Diclofenac Potassium, a human prescription drug labeled by Nivagen Pharmaceuticals, Inc.. This powder, for solution is formulated for oral use and contains diclofenac potassium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nivagen Pharmaceuticals, Inc. on December 15, 2025. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Diclofenac is used to relieve pain and swelling (inflammation) from various mild to moderate painful conditions. It is used to treat muscle aches, backaches, dental pain, menstrual cramps, and sports injuries. It also reduces pain, swelling, and joint stiffness caused by arthritis. Reducing these symptoms helps you do more of your normal daily activities. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.
How is this Nivagen Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 75834033801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.